Literature DB >> 16709943

Familial elevated factor VIII in children with symptomatic venous thrombosis and post-thrombotic syndrome: results of a multicenter study.

Wolfhart Kreuz1, Monika Stoll, Ralf Junker, Achim Heinecke, Rosemarie Schobess, Karin Kurnik, Reinhard Kelsch, Ulrike Nowak-Göttl.   

Abstract

OBJECTIVE: To evaluate the role of factor (F) VIII in children with non-cancer related venous thrombosis (DVT), post-thrombotic syndrome (PTS) or recurrent DVT. METHODS AND
RESULTS: FVIII levels were measured in White patients and age- and gender-matched healthy controls. Heritability of factor VIII was estimated in 99 pedigrees by the variance component method implemented in SOLAR. The group of 103 patients showed higher median values of FVIII than 206 controls [FVIII:Ag, 115 versus 96 IU/dL, P<0.0001; FVIII:C, 119 versus 106 IU/dL, P=0.0009], and had a significantly increased odds ratio (OR) for fibrinogen-adjusted elevated FVIII levels [FVIII >90th percentile versus values below the cut-off: FVIII:Ag, OR 4.3, 95% confidence interval (CI) 1.5 to 12.1; FVIII:C, OR 5.5, CI 2.03 to 15.06]. PTS occurred in 19 of 59 children and persisted in 5 individuals. Recurrent DVT was seen in 8 patients. The heritable(h2)/household(c2) components were calculated for FVIII:Ag levels (h2, 0.48+/-0.15, P=0.0008; c2, 0.21), and FVIII:C (h2, 0.61+/-0.15, P<0.0001; c2, 0.41). When incorporating h2 and c2 in the estimate, the phenotypic variance for FVIII:Ag levels is predominantly explained by h2, whereas c2 stayed significant in the model for FVIII:C (P=0.00002).
CONCLUSIONS: Elevated FVIII levels increase the DVT-risk in children.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16709943     DOI: 10.1161/01.ATV.0000227510.36653.ed

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  12 in total

1.  A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels.

Authors:  Kevin R Viel; Deepa K Machiah; Diane M Warren; Manana Khachidze; Alfonso Buil; Karl Fernstrom; Juan C Souto; Juan M Peralta; Todd Smith; John Blangero; Sandra Porter; Stephen T Warren; Jordi Fontcuberta; Jose M Soria; W Dana Flanders; Laura Almasy; Tom E Howard
Journal:  Blood       Date:  2007-01-05       Impact factor: 22.113

Review 2.  Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors.

Authors:  Neil A Goldenberg; Marco P Donadini; Susan R Kahn; Mark Crowther; Gili Kenet; Ulrike Nowak-Göttl; Marilyn J Manco-Johnson
Journal:  Haematologica       Date:  2010-06-30       Impact factor: 9.941

3.  Low-dose systemic thrombolytic therapy for deep vein thrombosis in pediatric patients.

Authors:  Sarah E Leary; Virginia L Harrod; Pedro A de Alarcon; Ulrike M Reiss
Journal:  J Pediatr Hematol Oncol       Date:  2010-03       Impact factor: 1.289

Review 4.  The roles of anatomic factors, thrombophilia, and antithrombotic therapies in childhood-onset arterial ischemic stroke.

Authors:  Timothy J Bernard; Marilyn J Manco-Johnson; Neil A Goldenberg
Journal:  Thromb Res       Date:  2010-10-13       Impact factor: 3.944

5.  Role of reduced ADAMTS13 in arterial ischemic stroke: a pediatric cohort study.

Authors:  Moritz Lambers; Neil A Goldenberg; Gili Kenet; Fenella J Kirkham; Daniela Manner; Timothy Bernard; Rolf M Mesters; Ralf Junker; Monika Stoll; Ulrike Nowak-Göttl
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

Review 6.  Markers of coagulation activation, inflammation and fibrinolysis as predictors of poor outcomes after pediatric venous thromboembolism: A systematic review and meta-analysis.

Authors:  Ayesha Zia; Joy Russell; Ravi Sarode; Surendranath R Veeram; Shellie Josephs; Kendra Malone; Song Zhang; Janna Journeycake
Journal:  Thromb Res       Date:  2017-10-07       Impact factor: 3.944

Review 7.  Pharmacokinetics, efficacy, and safety of LMWHs in venous thrombosis and stroke in neonates, infants and children.

Authors:  U Nowak-Göttl; C Bidlingmaier; A Krümpel; L Göttl; G Kenet
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

8.  Pediatric May-Thurner Syndrome-Systematic review and individual patient data meta-analysis.

Authors:  Laura Avila; Noelle Cullinan; Michael White; Marian Gaballah; Anne Marie Cahill; Deepti Warad; Vilmarie Rodriguez; Cristina Tarango; Anna Hoppmann; Stephen Nelson; Tomas Kuhn; Tina Biss; Aaron Weiss; Michael Temple; João G Amaral; Nour Amiri; Ana C Xavier; Samuele Renzi; Leonardo R Brandão
Journal:  J Thromb Haemost       Date:  2021-04-01       Impact factor: 5.824

9.  Characteristics of upper- and lower-extremity deep vein thrombosis and predictors of postthrombotic syndrome in children.

Authors:  Laura Avila; Nour Amiri; Riddhita De; Jennifer Vincelli; Eleanor Pullenayegum; Suzan Williams; Leonardo R Brandão
Journal:  Blood Adv       Date:  2021-10-12

10.  Venous Thromboembolism in Pediatric Inflammatory Bowel Disease: A Case-Control Study.

Authors:  Elana B Mitchel; Sara Rosenbaum; Christopher Gaeta; Jing Huang; Leslie J Raffini; Robert N Baldassano; Michelle R Denburg; Lindsey Albenberg
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-05-01       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.